Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury

ClinicalTrials.gov ID: NCT04096950

Public ClinicalTrials.gov record NCT04096950. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 3, 2026, 12:57 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Study to Investigate the Safety, Tolerability , Pharmacokinetics of Single Ascending Dose of MT-3921 in Subjects With Acute Spinal Cord Injury

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess the safety, tolerability and pharmacokinetics of MT-3921 in subjects with spinal cord injury.

Study identification

NCT ID
NCT04096950
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Tanabe Pharma America, Inc.
Industry
Enrollment
3 participants

Conditions and interventions

Interventions

Biological

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 18, 2020
Primary completion
Jan 5, 2021
Completion
Jan 5, 2021
Last update posted
May 14, 2023

2020 – 2021

United States locations

U.S. sites
13
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
UC Davis Medical Center Sacramento California 95816
Northwestern University / Shirley Ryan Ability LAB (SRALAB) Chicago Illinois 60611
Carle Foundation Hospital Urbana Illinois 61801
University of Michigan Ann Arbor Michigan 48109
University of Mississippi Medical Center Jackson Mississippi 39216
Washington University School of Medicine St Louis Missouri 63110
University of New Mexico Hospital Albuquerque New Mexico 87131
Carolinas Healthcare System / Atrium Health Charlotte North Carolina 28203
Vidant Medical Center Greenville North Carolina 27834
The Ohio State University Wexner Medical Center Columbus Ohio 43210
Thomas Jefferson University Philadelphia Pennsylvania 19107
VA Commonwealth Univ. School of Medicine Richmond Virginia 23298
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04096950, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 14, 2023 · Synced Sep 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04096950 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →